Safety and efficacy of topically administered netarsudil (Rhopressa™) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG).

Kelly A LearyKuan-Ting LinJuan P SteibelChristine D HarmanAndrás M Komáromy

Published in: Veterinary ophthalmology (2019)

Once or twice daily administration of netarsudil resulted in marginal and clinically irrelevant IOP decreases in normal and OAG-affected dogs. Except for conjunctival hyperemia, the drug was well tolerated.

Keyphrases

physical activity
emergency department